Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

RFK said there was a LC project funded by NIH whic

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 157601
(Total Views: 417)
Posted On: 09/04/2025 3:03:00 PM
Posted By: Enjay
Re: biloxiblues #156604
RFK said there was a LC project funded by NIH which spent a lot of money but it yielded nothing. It sounds like RECOVER is dead.

RFK mentioned one other doctor: Dr. Jordan Vaughn. Here is a summary of what ChatGPT said about him:

Dr. Vaughn has treated approximately 1,500–1,600 Long COVID patients, incorporating combinations of blood thinners (antiplatelet agents, anticoagulants) and supplements. Many patients reportedly experienced significant symptom relief.

Vaughn collaborates with notable researchers such as Resia Pretorius, Jaco Laubscher, and Douglas Kell. While his treatments are currently based on clinical observation and protocols, he has expressed interest in launching clinical trials to rigorously test his methods.

Dr. Vaughn treats Long COVID as a vascular (endothelial) disease, focusing on how the SARS-CoV-2 spike protein can cause endothelial damage and microvascular clotting (microclots), impairing oxygen delivery throughout the body.

While many patients report improvement, his methods remain largely outside mainstream clinical research and are not yet validated through published clinical trials or peer-reviewed studies.


(3)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us